JWA
JFS Wealth Advisors Portfolio holdings
AUM
$1.57B
1-Year Return
12.18%
This Quarter Return
+9.57%
1 Year Return
+12.18%
3 Year Return
+41.52%
5 Year Return
+65.5%
10 Year Return
+100.04%
AUM
$1.18B
AUM Growth
+$117M
(+11%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
46.46%
Holding
2,069
New
100
Increased
901
Reduced
658
Closed
75
Top Buys
| 1 |
Dimensional International Core Equity Market ETF
DFAI
|
+$8.67M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$5.86M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.62M |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$5.25M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.51M |
Top Sells
| 1 |
Invesco S&P International Developed Low Volatility ETF
IDLV
|
+$7.13M |
| 2 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$2.47M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$2.4M |
| 4 |
Invesco Municipal Opportunity Trust
VMO
|
+$2.35M |
| 5 |
EIM
Eaton Vance Municipal Bond Fund
EIM
|
+$2.34M |
Sector Composition
| 1 | Financials | 4.2% |
| 2 | Technology | 3.54% |
| 3 | Industrials | 1.04% |
| 4 | Consumer Discretionary | 0.94% |
| 5 | Energy | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Procore
PCOR
$10.6B
| $208 | ﹤0.01% |
3
+1
| +50% | +$69 |
|
1902
Pacific Biosciences
PACB
$375M
| $207 | ﹤0.01% |
21
-14
| -40% | -$138 |
|
1903
Stagwell
STGW
$1.43B
| $199 | ﹤0.01% |
30
+29
| +2,900% | +$192 |
|
1904
Cinemark Holdings
CNK
$3.16B
| $198 | ﹤0.01% |
14
-2
| -13% | -$28 |
|
1905
Gevo
GEVO
$397M
| $198 | ﹤0.01% |
170
-170
| -50% | -$198 |
|
1906
Middlesex Water
MSEX
$957M
| $197 | ﹤0.01% |
+3
| New | +$197 |
|
1907
Alkermes
ALKS
$4.7B
| $195 | ﹤0.01% |
+7
| New | +$195 |
|
1908
SPS Commerce
SPSC
$4.19B
| $194 | ﹤0.01% |
1
-1
| -50% | -$194 |
|
1909
Sarepta Therapeutics
SRPT
$1.84B
| $193 | ﹤0.01% |
2
-1
| -33% | -$97 |
|
1910
Embecta
EMBC
$857M
| $190 | ﹤0.01% |
10
-21
| -68% | -$399 |
|
1911
Marqeta
MQ
$2.73B
| $189 | ﹤0.01% |
27
+17
| +170% | +$119 |
|
1912
Vicor
VICR
$2.27B
| $180 | ﹤0.01% |
4
-2
| -33% | -$90 |
|
1913
EverCommerce
EVCM
$2.12B
| $177 | ﹤0.01% |
16
+6
| +60% | +$66 |
|
1914
Nu Skin
NUS
$570M
| $175 | ﹤0.01% |
9
-22
| -71% | -$428 |
|
|
SAGE
1915
DELISTED
Sage Therapeutics
SAGE
| $174 | ﹤0.01% |
8
-5
| -38% | -$109 |
|
1916
Ingles Markets
IMKTA
$1.33B
| $173 | ﹤0.01% |
2
+1
| +100% | +$87 |
|
|
AMPE
1917
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $171 | ﹤0.01% |
83
| – | – |
|
1918
HNI Corp
HNI
$2.16B
| $168 | ﹤0.01% |
4
+2
| +100% | +$84 |
|
1919
NBT Bancorp
NBTB
$2.3B
| $168 | ﹤0.01% |
4
| – | – |
|
1920
Evolent Health
EVH
$1.12B
| $166 | ﹤0.01% |
5
-17
| -77% | -$564 |
|
1921
Aurora
AUR
$10.6B
| $162 | ﹤0.01% |
+37
| New | +$162 |
|
1922
Vanguard Consumer Staples ETF
VDC
$7.63B
| $162 | ﹤0.01% |
1
| – | – |
|
1923
Rocket Companies
RKT
$43.1B
| $160 | ﹤0.01% |
11
-1
| -8% | -$15 |
|
1924
Talos Energy
TALO
$1.65B
| $157 | ﹤0.01% |
+11
| New | +$157 |
|
|
BORR
1925
Borr Drilling
BORR
$856M
| $155 | ﹤0.01% |
21
-2
| -9% | -$15 |
|